Susan Scheer1, Ling Hsu1, Sandra Schwarcz1, Sharon Pipkin1, Diane Havlir2, Susan Buchbinder2,3,4, Nancy A Hessol2,5. 1. HIV Epidemiology Section, San Francisco Department of Public Health. 2. Department of Medicine, University of California. 3. Department of Epidemiology and Biostatistics, University of California. 4. Bridge HIV, San Francisco Department of Public Health. 5. Department of Clinical Pharmacy, University of California.
Abstract
Background: San Francisco has launched interventions to reduce new human immunodeficiency virus (HIV) infections and HIV-associated morbidity and mortality during the San Francisco "Getting to Zero" era. We measured recent changes in HIV care indicators to assess the success of these interventions. Methods: San Francisco residents with newly diagnosed HIV infection, diagnosed from 2009 to 2014, were included. We measured temporal changes from HIV diagnosis to (1) linkage to care in within ≤3 months, (2) initiation of antiretroviral therapy (ART) within ≤12 months, (3) viral suppression within ≤12 months, (4) development of AIDS within ≤3 months, (5) death within ≤12 months, and (6) retention in care 6-12 months after linkage. Kaplan-Meier analyses stratified by year of HIV diagnosis measured time from diagnosis to linkage, ART initiation, viral suppression, AIDS, and death. Results: Overall, the number of new diagnoses declined from 473 in 2009 to 329 in 2014. The proportion of new diagnoses among men (P = .005), Latinos and Asian/Pacific Islanders (P = .02), and men who have sex with men (P = .003) increased. ART initiation and viral suppression ≤12 months after diagnosis increased (P < .001), while the proportion with AIDS diagnosed ≤3 months after HIV diagnosis declined (P < .001). Time to ART initiation and time to viral suppression were significantly shorter in more recent years of diagnosis (P < .001). Time from HIV to AIDS diagnosis was significantly longer in more recent years (P < .001). Retention in care did not significantly change. Conclusions: In San Francisco new HIV diagnoses have declined and HIV care indicators have improved during the Getting to Zero era. Continued success requires attention to vulnerable populations and monitoring to adjust programmatic priorities.
Background: San Francisco has launched interventions to reduce new human immunodeficiency virus (HIV) infections and HIV-associated morbidity and mortality during the San Francisco "Getting to Zero" era. We measured recent changes in HIV care indicators to assess the success of these interventions. Methods: San Francisco residents with newly diagnosed HIV infection, diagnosed from 2009 to 2014, were included. We measured temporal changes from HIV diagnosis to (1) linkage to care in within ≤3 months, (2) initiation of antiretroviral therapy (ART) within ≤12 months, (3) viral suppression within ≤12 months, (4) development of AIDS within ≤3 months, (5) death within ≤12 months, and (6) retention in care 6-12 months after linkage. Kaplan-Meier analyses stratified by year of HIV diagnosis measured time from diagnosis to linkage, ART initiation, viral suppression, AIDS, and death. Results: Overall, the number of new diagnoses declined from 473 in 2009 to 329 in 2014. The proportion of new diagnoses among men (P = .005), Latinos and Asian/Pacific Islanders (P = .02), and men who have sex with men (P = .003) increased. ART initiation and viral suppression ≤12 months after diagnosis increased (P < .001), while the proportion with AIDS diagnosed ≤3 months after HIV diagnosis declined (P < .001). Time to ART initiation and time to viral suppression were significantly shorter in more recent years of diagnosis (P < .001). Time from HIV to AIDS diagnosis was significantly longer in more recent years (P < .001). Retention in care did not significantly change. Conclusions: In San Francisco new HIV diagnoses have declined and HIV care indicators have improved during the Getting to Zero era. Continued success requires attention to vulnerable populations and monitoring to adjust programmatic priorities.
Authors: Robert M Grant; Peter L Anderson; Vanessa McMahan; Albert Liu; K Rivet Amico; Megha Mehrotra; Sybil Hosek; Carlos Mosquera; Martin Casapia; Orlando Montoya; Susan Buchbinder; Valdilea G Veloso; Kenneth Mayer; Suwat Chariyalertsak; Linda-Gail Bekker; Esper G Kallas; Mauro Schechter; Juan Guanira; Lane Bushman; David N Burns; James F Rooney; David V Glidden Journal: Lancet Infect Dis Date: 2014-07-22 Impact factor: 25.071
Authors: Qiang Xia; Rachael Lazar; Marie A Bernard; Paul McNamee; Demetre C Daskalakis; Lucia V Torian; Sarah L Braunstein Journal: J Acquir Immune Defic Syndr Date: 2016-11-01 Impact factor: 3.731
Authors: Julia L Marcus; Leo B Hurley; Charles Bradley Hare; Dong Phuong Nguyen; Tony Phengrasamy; Michael J Silverberg; Juliet E Stoltey; Jonathan E Volk Journal: J Acquir Immune Defic Syndr Date: 2016-12-15 Impact factor: 3.731
Authors: Peter F Rebeiro; Stephen J Gange; Michael A Horberg; Alison G Abraham; Sonia Napravnik; Hasina Samji; Baligh R Yehia; Keri N Althoff; Richard D Moore; Mari M Kitahata; Timothy R Sterling; Frank C Curriero Journal: PLoS One Date: 2016-01-11 Impact factor: 3.240
Authors: Sheena McCormack; David T Dunn; Monica Desai; David I Dolling; Mitzy Gafos; Richard Gilson; Ann K Sullivan; Amanda Clarke; Iain Reeves; Gabriel Schembri; Nicola Mackie; Christine Bowman; Charles J Lacey; Vanessa Apea; Michael Brady; Julie Fox; Stephen Taylor; Simone Antonucci; Saye H Khoo; James Rooney; Anthony Nardone; Martin Fisher; Alan McOwan; Andrew N Phillips; Anne M Johnson; Brian Gazzard; Owen N Gill Journal: Lancet Date: 2015-09-09 Impact factor: 79.321
Authors: Johanne E Morne; James M Tesoriero; Erika G Martin; Guthrie S Birkhead; David R Holtgrave; Karen Hagos; Howard Zucker Journal: Public Health Rep Date: 2020 Jul/Aug Impact factor: 2.792
Authors: Matthew A Spinelli; Nancy A Hessol; Sandy Schwarcz; Ling Hsu; Maree-Kay Parisi; Sharon Pipkin; Susan Scheer; Diane Havlir; Susan P Buchbinder Journal: AIDS Date: 2019-09-01 Impact factor: 4.177
Authors: Erika G Martin; Roderick H MacDonald; Daniel E Gordon; Carol-Ann Swain; Travis O'Donnell; John Helmeset; Adenantera Dwicaksono; James M Tesoriero Journal: Public Health Rep Date: 2020 Jul/Aug Impact factor: 2.792
Authors: Glenda N Baguso; Caitlin M Turner; Glenn-Milo Santos; H Fisher Raymond; Carol Dawson-Rose; Jess Lin; Erin C Wilson Journal: J Int AIDS Soc Date: 2019-04 Impact factor: 5.396
Authors: Nadia Hanum; Valentina Cambiano; Janey Sewell; Alison J Rodger; Nneka Nwokolo; David Asboe; Richard Gilson; Amanda Clarke; Ada R Miltz; Simon Collins; Valerie Delpech; Sara Croxford; Andrew N Phillips; Fiona C Lampe Journal: PLoS Med Date: 2021-06-18 Impact factor: 11.069